-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Dongcheng Pharmaceutical (002675.SZ) announced that the company received a notice from its wholly-owned subsidiary Yantai Dongcheng North Pharmaceutical Co., Ltd. (“Dongcheng North”) to receive the “Drug Supplement Application Approval Notice” issued by the State Drug Administration, and that the new specification (0.2ml: 5000axAIU) for heparin sodium injection was approved for listing.

Zhitongcaijing·12/09/2025 10:49:05
Listen to the news
Zhitong Finance App News, Dongcheng Pharmaceutical (002675.SZ) announced that the company received a notice from its wholly-owned subsidiary Yantai Dongcheng North Pharmaceutical Co., Ltd. (“Dongcheng North”) to receive the “Drug Supplement Application Approval Notice” issued by the State Drug Administration, and that the new specification (0.2ml: 5000axAIU) for heparin sodium injection was approved for listing.